Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Combination of capecitabine and bevacizumab improves progression-free survival in metastatic breast cancer

Dr Joseph Gligorov - Assistance Publique Hôpitaux de Paris, Paris, France
Combination of capecitabine and bevacizumab improves progression-free survival in metastatic breast cancer ( Dr Joseph Gligorov - Assistance Publique Hôpitaux de Paris, Paris, France )
2 Oct 2014

Research shows chemotherapy has no negative effects on babies in utero

Prof Frederic Amant - University Hospital Leuven, Leuven, Belgium
Research shows chemotherapy has no negative effects on babies in utero ( Prof Frederic Amant - University Hospital Leuven, Leuven, Belgium )
1 Oct 2014

Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer

Dr Lucas Minig - Valencia Institute of Oncology, Valencia, Spain
Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer ( Dr Lucas Minig - Valencia Institute of Oncology, Valencia, Spain )
1 Oct 2014

Raising awareness about head and neck cancer through the Make Sense campaign

Prof Jean-Louis Lefebvre, Northern France Comprehensive Cancer Centre, Lille, France
Raising awareness about head and neck cancer through the Make Sense campaign ( Prof Jean-Louis Lefebvre, Northern France Comprehensive Cancer Centre, Lille, France )
1 Oct 2014

Cancer care in developing countries

Prof Ian Magrath - International Network for Cancer Treatment and Research, Brussels, Belgium
Cancer care in developing countries ( Prof Ian Magrath - International Network for Cancer Treatment and Research, Brussels, Belgium )
1 Oct 2014

Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma

Dr Caroline Robert - Gustave Roussy, Villejuif, France
Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma ( Dr Caroline Robert - Gustave Roussy, Villejuif, France )
29 Sep 2014

Nivolumab potentially superior to standard chemo in advanced melanoma

Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab potentially superior to standard chemo in advanced melanoma ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
29 Sep 2014

Targeted therapy for iodine-refractory thyroid cancer

Dr Makoto Tahara - National Cancer Center Hospital East, Kashiwa, Japan
Targeted therapy for iodine-refractory thyroid cancer ( Dr Makoto Tahara - National Cancer Center Hospital East, Kashiwa, Japan )
29 Sep 2014

Young oncologists bridging the gap between translational and clinical cancer research

Prof Joan Seoane - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Young oncologists bridging the gap between translational and clinical cancer research ( Prof Joan Seoane - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
29 Sep 2014

Questions raised about the future of lung cancer vaccination?

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Questions raised about the future of lung cancer vaccination? ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
29 Sep 2014

Cancer care as a human right in low-income countries

Prof Eduardo Cazap - SLACOM, Buenos Aires, Argentina
Cancer care as a human right in low-income countries ( Prof Eduardo Cazap - SLACOM, Buenos Aires, Argentina )
29 Sep 2014

PD-L1 protein a possible immunotherapy target in mesothelioma

Prof Rolf Stahel - University Hospital of Zurich, Zurich, Switzerland
PD-L1 protein a possible immunotherapy target in mesothelioma ( Prof Rolf Stahel - University Hospital of Zurich, Zurich, Switzerland )
29 Sep 2014